跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARGOCID teicoplanin 400mg injection - TGA Drug Approval Details
Approvals
/
TGA
/
TARGOCID teicoplanin 400mg injection
Approved
STANDARD
TARGOCID teicoplanin 400mg injection
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
f95c44203ee0f2c2
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
f95c44203ee0f2c2
Product Name
TARGOCID teicoplanin 400mg injection
Artg Id
47886
Artg Name
TARGOCID teicoplanin 400mg powder for injection vial with diluent ampoule
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
1994-02-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9ab85eb0d871a7c1cf3245c3319fc5df.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/43fb54c27f4e28deb5e597463e512975.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
f95c44203ee0f2c2
Type
Standard
Back to TGA Approvals